Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myeloma

Authors: Terpos, Evangelos ^{1, ∗}, Malandrakis, Panagiotis ¹, Ntanasis-Stathopoulos, Ioannis ¹, Kostopoulos, Ioannis V. ², Eleutherakis-Papaiakovou, Evangelos ¹, Kanellias, Nikolaos ¹, Spiliopoulou, Vasiliki ¹, Migkou, Magdalini ¹, Fotiou, Despina ¹, Theodorakakou, Foteini ¹, Kastritis, Efstathios ¹, Gavriatopoulou, Maria ¹, Tsitsilonis, Ourania E. ², Dimopoulos, Meletios-Athanasios ^{1, 3}

Source: In Blood 15 May 2025 145(20):2353-2360

PARP inhibitors during conception and pregnancy in breast cancer

Authors: Zagouri, Flora ^⁎, Dimopoulos, Meletios-Athanasios, Andrikopoulou, Angeliki

Source: In Critical Reviews in Oncology / Hematology June 2025 210

Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia

Authors: Heyman, Benjamin M. ^{1, ∗}, Opat, Stephen S. ², Wahlin, Björn E. ³, Dimopoulos, Meletios-Athanasios C. ⁴, Castillo, Jorge J. ⁵, Tedeschi, Alessandra ⁶, Tam, Constantine S. ^{7, 8}, Buske, Christian ⁹, Owen, Roger G. ¹⁰, Leblond, Véronique ¹¹, Trotman, Judith ¹², Barnes, Gisoo ¹³, Chan, Wai Y. ¹³, Schneider, Jingjing ¹³, Allewelt, Heather ¹³, Cohen, Aileen ¹³, Matous, Jeffrey V. ¹⁴

Source: In Blood Advances 25 February 2025 9(4):722-728

Evaluation of Clinical Characteristics and Prognostic Factors of Early Progressive Disease (EPD) in Newly Diagnosed Multiple Myeloma Patients: Real-World Data of the Greek Myeloma Study Group

Authors: Katodritou, Eirini ^{1, ⁎}, Kastritis, Efstathios ², Dalampira, Dimitra ¹, Fotiou, Despina ², Theodorakakou, Fotini ², Delimpasi, Sosana ³, Spanoudakis, Emmanouil ⁴, Ntanasis-Stathopoulos, Ioannis ², Papadopoulou, Theodosia ¹, Sevastoudi, Aggeliki ¹, Triantafyllou, Theodora ¹, Daiou, Aikaterini ¹, Pouli, Anastasia ⁵, Migkou, Magda ², Gavriatopoulou, Maria ², Verrou, Evgenia ¹, Kyrtsonis, Marie Christine ⁶, Dimopoulos, Meletios-Athanasios ², Terpos, Evangelos ²

Source: In Clinical Lymphoma, Myeloma and Leukemia January 2025

Isatuximab plus carfilzomib–dexamethasone versus carfilzomib–dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trial

Authors: Yong, Kwee ^*, Martin, Thomas, Dimopoulos, Meletios-Athanasios, Mikhael, Joseph, Capra, Marcelo, Facon, Thierry, Hajek, Roman, Špička, Ivan, Baker, Ross, Kim, Kihyun, Martinez, Gracia, Min, Chang-Ki, Pour, Ludek, Leleu, Xavier, Oriol, Albert, Koh, Youngil, Suzuki, Kenshi, Casca, France, Macé, Sandrine, Risse, Marie-Laure, Moreau, Philippe

Source: In The Lancet Haematology October 2024 11(10):e741-e750

Oral SERDs alone or in combination with CDK 4/6 inhibitors in breast cancer: Current perspectives and clinical trials

Authors: Apostolidou, Kleoniki, Zografos, Eleni, Papatheodoridi, Maria Alkistis, Fiste, Oraianthi, Dimopoulos, Meletios Athanasios, Zagouri, Flora

Source: In The Breast June 2024 75

Chemotherapy response score as a predictor of survival in ovarian cancer patients

Authors: Rodolakis, Ioannis, Liontos, Michalis, Pergialiotis, Vasilios, Haidopoulos, Dimitrios, Kaparelou, Maria, Efthimios Vlachos, Dimitrios, Dimopoulos, Meletios Athanasios, Loutradis, Dimitrios, Rodolakis, Alexandros, Bamias, Aristotelis, Thomakos, Nikolaos

Source: In European Journal of Obstetrics & Gynecology and Reproductive Biology May 2024 296:233-238

Cardiovascular complications of ribociclib in breast cancer patients

Authors: Fiste, Oraianthi, Mavrothalassitis, Evangelos, Apostolidou, Kleoniki, Trika, Chrysanthi, Liontos, Michalis, Koutsoukos, Konstantinos, Kaparelou, Maria, Dimitrakakis, Constantine, Gavriatopoulou, Maria, Dimopoulos, Meletios Athanasios, Zagouri, Flora

Source: In Critical Reviews in Oncology / Hematology April 2024 196

Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study

Authors: Dimopoulos, Meletios Athanasios ^*, Hungria, Vania T M, Radinoff, Atanas, Delimpasi, Sosana, Mikala, Gabor, Masszi, Tamas, Li, Jian, Capra, Marcelo, Maiolino, Angelo, Pappa, Vasiliki, Chraniuk, Dominik, Osipov, Iurii, Leleu, Xavier, Low, Michael, Matsumoto, Morio, Sule, Neal, Li, Mary, McKeown, Astrid, He, Wei, Bright, Shelley, Currie, Brooke, Perera, Sue, Boyle, Julia, Roy-Ghanta, Sumita, Opalinska, Joanna, Weisel, Katja

Source: In The Lancet Haematology October 2023 10(10):e801-e812

Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies

Authors: Sonneveld, Pieter, Richardson, Paul G., Ludwig, Heinz, Dimopoulos, Meletios-Athanasios, Schjesvold, Fredrik H., Hájek, Roman, Abdulhaq, Haifaa, Thuresson, Marcus, Norin, Stefan, Bakker, Nicolaas A., Mateos, Maria-Victoria

Source: In Clinical Lymphoma, Myeloma and Leukemia September 2023 23(9):687-696

Highly Sensitive Detection Method of CXCR4 Tumor Hotspot Mutations by Drop-Off Droplet Digital PCR in Patients with IgM Monoclonal Gammopathies

Authors: Markou, Athina N., Bagratuni, Tina, Tsakiri, Christina, Tserpeli, Victoria, Skourti, Stamatia, Mavrianou Koutsoukou, Nefeli, Papadimou, Alexandra, Terpos, Evangelos, Kastritis, Efstathios, Lianidou, Evi, Dimopoulos, Meletios-Athanasios

Source: In The Journal of Molecular Diagnostics July 2023 25(7):502-512

Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer

Authors: Andrikopoulou, Angeliki ^{1, *}, Liontos, Michalis ¹, Skafida, Efthymia ¹, Koutsoukos, Konstantinos ¹, Apostolidou, Kleoniki ¹, Kaparelou, Maria ¹, Rouvalis, Angeliki ¹, Bletsa, Garyfallia ², Dimopoulos, Meletios-Athanasios ¹, Zagouri, Flora ¹

Source: In International Journal of Gynecological Cancer April 2023 33(4):571-576

Diagnostic and Prognostic Value of Non-late Gadolinium Enhancement Cardiac Magnetic Resonance Parameters in Cardiac Amyloidosis

Authors: Briasoulis, Alexandros, Lama, Niki, Rempakos, Athanasios, Theodorakakou, Foteini, Stamatelopoulos, Kimon, Dimopoulos, Meletios Athanasios, Kelekis, Nikolaos, Kastritis, Efstathios

Source: In Current Problems in Cardiology April 2023 48(4)

Delta SARS-CoV-2 variant is entirely substituted by the omicron variant during the fifth COVID-19 wave in Attica region

Authors: Galani, Aikaterini, Markou, Athina, Dimitrakopoulos, Lampros, Kontou, Aikaterini, Kostakis, Marios, Kapes, Vasileios, Diamantopoulos, Marios A., Adamopoulos, Panagiotis G., Avgeris, Margaritis, Lianidou, Evi, Scorilas, Andreas, Paraskevis, Dimitrios, Tsiodras, Sotirios, Dimopoulos, Meletios-Athanasios, Thomaidis, Nikolaos

Source: In Science of the Total Environment 15 January 2023 856 Part 1

Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies

Authors: Alexopoulos, Harry, Trougakos, Ioannis P, Dimopoulos, Meletios-Athanasios, Terpos, Evangelos

Source: In European Journal of Internal Medicine January 2023 107:7-16

Machine learning applications in gynecological cancer: A critical review

Authors: Fiste, Oraianthi, Liontos, Michalis, Zagouri, Flora, Stamatakos, Georgios, Dimopoulos, Meletios Athanasios

Source: In Critical Reviews in Oncology / Hematology November 2022 179

Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individuals

Authors: Mavragani, Clio P., Skarlis, Charalampos, Kostopoulos, Ioannis V., Maratou, Eirini, Moutsatsou, Paraskevi, Terpos, Evangelos, Tsitsilonis, Ourania E., Dimopoulos, Meletios-Athanasios, Sfikakis, Petros P.

Source: In Cytokine September 2022 157

Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice.

Authors: Ntanasis-Stathopoulos, Ioannis, Koutoulidis, Vassilis, Malandrakis, Panagiotis, Fotiou, Despina, Spiliopoulou, Vasiliki, Filippatos, Charalampos, Migkou, Magdalini, Kanellias, Nikolaos, Theodorakakou, Foteini, Eleutherakis-Papaiakovou, Evangelos, Kastritis, Efstathios, Terpos, Evangelos, Dimopoulos, Meletios-Athanasios, Moulopoulos, Lia-Angela, Gavriatopoulou, Maria

Source: Journal of Clinical Medicine; Apr2025, Vol. 14 Issue 7, p2224, 9p

Subject Terms: MULTIPLE myeloma, COMPUTED tomography, ASYMPTOMATIC patients, BONE diseases, PATIENT monitoring

Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome.

Authors: Soureas, Konstantinos, Malandrakis, Panagiotis, Papadimitriou, Maria-Alexandra, Minopoulos, Christos, Ntanasis-Stathopoulos, Ioannis, Liacos, Christine-Ivy, Gavriatopoulou, Maria, Kastritis, Efstathios, Dimopoulos, Meletios-Athanasios, Scorilas, Andreas, Avgeris, Margaritis, Terpos, Evangelos

Source: Blood Cancer Journal; 3/15/2025, Vol. 15 Issue 1, p1-10, 10p

Subject Terms: PLASMA cells, MEDICAL sciences, OVERALL survival, MULTIPLE myeloma, DECISION making

Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma

Authors: Dimopoulos, Meletios-Athanasios, Richardson, Paul, Lonial, Sagar

Source: In Clinical Lymphoma, Myeloma and Leukemia July 2022 22(7):460-473